"Expectorants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.
| Descriptor ID |
D005100
|
| MeSH Number(s) |
D27.505.954.796.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Expectorants".
Below are MeSH descriptors whose meaning is more specific than "Expectorants".
This graph shows the total number of publications written about "Expectorants" by people in this website by year, and whether "Expectorants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1998 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Expectorants" by people in Profiles.
-
Sharpe SM, Qin X, Lu Q, Feketeova E, Palange DC, Dong W, Sheth SU, Lee MA, Reino D, Xu DZ, Deitch EA. Loss of the intestinal mucus layer in the normal rat causes gut injury but not toxic mesenteric lymph nor lung injury. Shock. 2010 Nov; 34(5):475-81.
-
Cammarota G, Branca G, Ardito F, Sanguinetti M, Ianiro G, Cianci R, Torelli R, Masala G, Gasbarrini A, Fadda G, Landolfi R, Gasbarrini G. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol. 2010 Sep; 8(9):817-820.e3.
-
Denaro V, Di Martino A, Longo UG, Costa V, Papalia R, Forriol F, Denaro L. Effectiveness of a mucolythic agent as a local adjuvant in revision lumbar spine surgery. Eur Spine J. 2008 Dec; 17(12):1752-6.
-
Geller DE, Eigen H, Fiel SB, Clark A, Lamarre AP, Johnson CA, Konstan MW. Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Pediatr Pulmonol. 1998 Feb; 25(2):83-7.
-
Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies. Semin Oncol. 1996 Jun; 23(3 Suppl 6):11-5.
-
Fiel SB. Chronic obstructive pulmonary disease. Mortality and mortality reduction. Drugs. 1996; 52 Suppl 2:55-60; discussion 60-1.
-
Fiel SB, Fuchs HJ, Johnson C, Gonda I, Clark AR. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group. Chest. 1995 Jul; 108(1):153-6.
-
Fiel SB. Clinical management of pulmonary disease in cystic fibrosis. Lancet. 1993 Apr 24; 341(8852):1070-4.